Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China. Zhang Y, Zhang Y, Shi X, Lin B, et al. Thromb Haemost 2022;122:842-852.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Zhang Y, Shi X, Lin B, et al. Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China. Thromb Haemost 2022;122:842-852.
PMID: 34428831